GENOWAYACT. Aktie
3,28EUR | -0,02EUR | -0,61% |
WKN DE: A0MRJ4 / ISIN: FR0004053510
Personal
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 0 | 125 | 131 | 133 | 0 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,00 | 0,11 | 0,13 | 0,15 | 0,00 |
Bilanz (in Mio. EUR) - Aktiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 15 | 19 | 20 | 18 | 0 |
Summe Anlagevermögen | 13 | 13 | 13 | 14 | 0 |
Summe Aktiva | 27 | 32 | 33 | 32 | 0 |
Bilanz (in Mio. EUR) - Passiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Fremdkapital | 20 | 19 | 19 | 16 | 0 |
Summe Eigenkapital | 8 | 13 | 14 | 15 | 18 |
Summe Passiva | 27 | 32 | 33 | 32 | 0 |
Adresse
31, Rue Saint Jean de Dieu, 69007 Lyon | |
Telefon | +33 (4) 22-12-31-25 |
Internet | http://www.genoway.com |
Management
Alexandre Fraichard
Director & General Manager |
Andre Tartar
Director |
Benjamin Bruneau
Chief Financial Officer |
Christian Grenier
Chairman & Chief Executive Officer |
Jean-Louis Menard
Director |
Laurent Fraisse
Director |
Olivier Antoine M. Charmeil
Director |
Patrick Blain
Director |
Raffy Kazandjian
Director |